Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase 3 trial.
暂无分享，去创建一个
G. Lou | Q. Zhou | B. Kong | M. Mirza | Yan Zhang | L. Chen | H. Cui | Jia-xin Yang | Z. Liu | R. An | M. Hao | Y. Zhang | Yunong Gao | J. Zhu | G. Abulizi | R. Yin | Jihong Liu | Q. Chen | L. Wu | X. Wu | Li Wang | Jianqing Zhu | C. Zhang | X. Tian | J. Yang | J. H. Liu | J. Wang | Y. Gao | D. Wang | H. Yang | Y. Huang | G. Li | K. Wang | X. Yan | X. Lu | W. Lu | L. Wang | X. Huang | H. Wen | J. Hou | Q. Chen | Jun Wang | Xin Lu | Q. Zhou | X. Lu | L. Wu | X. Lu | C. Zhang | W. Lu | Yan Zhang | Yunong Gao | Jiaxin Yang